Acura Pharma (ACUR) Reports Q4 Loss of $0.06
Tweet
Share
E-mailGet Alerts ACUR Hot Sheet
Price: $0.00 --0%
Financial Fact:
Income (loss) from operations: -2.07M
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Income (loss) from operations: -2.07M
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
Acura Pharma (NASDAQ: ACUR) reported Q4 EPS of ($0.06), versus ($0.07) reported last year.
For earnings history and earnings-related data on Acura Pharma (ACUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Marvell (MRVL) Stock: Risk/Reward Skewed to the Upside Near-Term Following Selloff, Says Analyst
- AiRWA receives Nasdaq deficiency notice over late 10-K filing
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
